Tramadol Use in Perioperative Care and Current Controversies

Curr Pain Headache Rep. 2022 Mar;26(3):241-246. doi: 10.1007/s11916-022-01021-1. Epub 2022 Feb 18.

Abstract

Purpose of review: The aim of this review is to discuss the use of tramadol in the perioperative period. There is no doubt that tramadol has revolutionized pain treatment, making it important to understand the pharmacokinetics and pharmacodynamics in order to provide patients with the safest and most effective analgesia.

Recent findings: Tramadol is a centrally acting synthetic analgesic with a multimode of action used to help treat moderate to severe pain. Pharmacologically, the unique opioid acts as a serotonin-norepinephrine reuptake inhibitor, while its metabolite, O-desmethyltramadol, acts on the μ-opioid receptor. The analgesic strength of tramadol is about one-tenth that of morphine, making it a relatively safe analgesic. Potential side effects of tramadol include nausea, vomiting, constipation, pruritus, and respiratory depression; however, the severity of these symptoms is minimal compared to traditional opioids. Although some of the perioperative uses of tramadol may be rare, it is a pain management option to consider when alternatives have proved ineffective.

Keywords: Perioperative pain; Pharmacogenetic polymorphism; Safety and controversy; Serotonin syndrome; Tonsillectomy and/or adenoidectomy; Tramadol.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Humans
  • Morphine / therapeutic use
  • Pain / drug therapy
  • Perioperative Care
  • Tramadol* / adverse effects

Substances

  • Analgesics, Opioid
  • Tramadol
  • Morphine